vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and Community West Bancshares (CWBC). Click either name above to swap in a different company.

CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $38.3M, roughly 1.0× Community West Bancshares). On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 11.6%). Community West Bancshares produced more free cash flow last quarter ($43.6M vs $19.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 36.0%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.

CDXS vs CWBC — Head-to-Head

Bigger by revenue
CDXS
CDXS
1.0× larger
CDXS
$38.9M
$38.3M
CWBC
Growing faster (revenue YoY)
CDXS
CDXS
+69.8% gap
CDXS
81.3%
11.6%
CWBC
More free cash flow
CWBC
CWBC
$24.0M more FCF
CWBC
$43.6M
$19.6M
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
36.0%
CWBC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
CWBC
CWBC
Revenue
$38.9M
$38.3M
Net Profit
$9.6M
Gross Margin
94.8%
Operating Margin
27.1%
40.0%
Net Margin
24.7%
Revenue YoY
81.3%
11.6%
Net Profit YoY
192.5%
EPS (diluted)
$0.13
$0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
CWBC
CWBC
Q4 25
$38.9M
$38.3M
Q3 25
$8.6M
$37.9M
Q2 25
$15.3M
$35.7M
Q1 25
$7.5M
$34.8M
Q4 24
$21.5M
$34.3M
Q3 24
$12.8M
$31.3M
Q2 24
$8.0M
$30.5M
Q1 24
$17.1M
$20.7M
Net Profit
CDXS
CDXS
CWBC
CWBC
Q4 25
$9.6M
Q3 25
$-19.6M
$10.9M
Q2 25
$-13.3M
$7.8M
Q1 25
$-20.7M
$8.3M
Q4 24
$-10.4M
Q3 24
$-20.6M
$3.4M
Q2 24
$-22.8M
$-6.3M
Q1 24
$-11.5M
$3.7M
Gross Margin
CDXS
CDXS
CWBC
CWBC
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
CWBC
CWBC
Q4 25
27.1%
40.0%
Q3 25
-220.3%
39.8%
Q2 25
-83.9%
30.2%
Q1 25
-271.6%
32.7%
Q4 24
-34.2%
31.0%
Q3 24
-129.0%
13.3%
Q2 24
-284.9%
-25.9%
Q1 24
-69.6%
23.2%
Net Margin
CDXS
CDXS
CWBC
CWBC
Q4 25
24.7%
Q3 25
-228.1%
28.7%
Q2 25
-86.6%
22.0%
Q1 25
-274.3%
23.8%
Q4 24
-48.4%
Q3 24
-160.8%
10.8%
Q2 24
-285.2%
-20.7%
Q1 24
-67.4%
17.8%
EPS (diluted)
CDXS
CDXS
CWBC
CWBC
Q4 25
$0.13
$0.58
Q3 25
$-0.22
$0.57
Q2 25
$-0.16
$0.41
Q1 25
$-0.25
$0.44
Q4 24
$-0.12
$0.29
Q3 24
$-0.29
$0.18
Q2 24
$-0.32
$-0.33
Q1 24
$-0.16
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
CWBC
CWBC
Cash + ST InvestmentsLiquidity on hand
$78.2M
$119.0M
Total DebtLower is stronger
$40.1M
$69.5M
Stockholders' EquityBook value
$50.5M
$409.6M
Total Assets
$147.8M
$3.7B
Debt / EquityLower = less leverage
0.79×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
CWBC
CWBC
Q4 25
$78.2M
$119.0M
Q3 25
$58.7M
$121.6M
Q2 25
$66.3M
$134.4M
Q1 25
$59.8M
$148.4M
Q4 24
$73.5M
$120.4M
Q3 24
$90.3M
$149.0M
Q2 24
$73.2M
$109.7M
Q1 24
$85.5M
$61.0M
Total Debt
CDXS
CDXS
CWBC
CWBC
Q4 25
$40.1M
$69.5M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
$69.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
CWBC
CWBC
Q4 25
$50.5M
$409.6M
Q3 25
$38.5M
$397.6M
Q2 25
$55.6M
$380.0M
Q1 25
$49.6M
$372.2M
Q4 24
$66.9M
$362.7M
Q3 24
$73.4M
$363.5M
Q2 24
$61.4M
$350.2M
Q1 24
$79.3M
$211.7M
Total Assets
CDXS
CDXS
CWBC
CWBC
Q4 25
$147.8M
$3.7B
Q3 25
$124.0M
$3.6B
Q2 25
$138.2M
$3.6B
Q1 25
$128.9M
$3.6B
Q4 24
$149.0M
$3.5B
Q3 24
$148.2M
$3.5B
Q2 24
$132.0M
$3.5B
Q1 24
$149.6M
$2.4B
Debt / Equity
CDXS
CDXS
CWBC
CWBC
Q4 25
0.79×
0.17×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
0.19×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
CWBC
CWBC
Operating Cash FlowLast quarter
$20.1M
$46.1M
Free Cash FlowOCF − Capex
$19.6M
$43.6M
FCF MarginFCF / Revenue
50.3%
113.9%
Capex IntensityCapex / Revenue
1.3%
6.6%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$77.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
CWBC
CWBC
Q4 25
$20.1M
$46.1M
Q3 25
$-7.7M
$13.2M
Q2 25
$-18.0M
$11.5M
Q1 25
$-13.8M
$11.1M
Q4 24
$-16.5M
$22.2M
Q3 24
$-13.0M
$7.8M
Q2 24
$-12.2M
$5.2M
Q1 24
$-7.8M
$4.0M
Free Cash Flow
CDXS
CDXS
CWBC
CWBC
Q4 25
$19.6M
$43.6M
Q3 25
$-7.9M
$12.8M
Q2 25
$-20.5M
$10.6M
Q1 25
$-15.1M
$10.8M
Q4 24
$-18.2M
$17.2M
Q3 24
$-14.0M
$5.2M
Q2 24
$-12.6M
$4.8M
Q1 24
$-8.9M
$3.6M
FCF Margin
CDXS
CDXS
CWBC
CWBC
Q4 25
50.3%
113.9%
Q3 25
-91.7%
33.7%
Q2 25
-133.6%
29.6%
Q1 25
-199.6%
30.9%
Q4 24
-85.0%
50.0%
Q3 24
-109.0%
16.7%
Q2 24
-157.5%
15.7%
Q1 24
-52.2%
17.3%
Capex Intensity
CDXS
CDXS
CWBC
CWBC
Q4 25
1.3%
6.6%
Q3 25
2.1%
1.1%
Q2 25
16.4%
2.7%
Q1 25
16.7%
0.9%
Q4 24
8.3%
14.7%
Q3 24
7.8%
8.1%
Q2 24
5.0%
1.4%
Q1 24
6.6%
2.1%
Cash Conversion
CDXS
CDXS
CWBC
CWBC
Q4 25
2.09×
Q3 25
1.21×
Q2 25
1.47×
Q1 25
1.33×
Q4 24
Q3 24
2.29×
Q2 24
Q1 24
1.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons